Evidence map›Paper›PMID 40735860›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Revisiting Alma Ata: A Blueprint for Cancer Care.

Javier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla, Alicia de Luna Aguilar, Antonio-David Lazaro-Sanchez, Asia Ferrández-Arias, Paula Rodríguez Payá, Beatriz Grau Mirete, Teresa Quintanar Verduguez, Elena Asensio Martinez and 5 more

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Javier-David Benitez-FuentesDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.ORCID 0000-0001-8827-2497
Rodrigo Lastra Del PradoRIO Working Group, Zaragoza, Spain.
Miguel Borregon-RivillaDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.
Alicia de Luna AguilarRIO Working Group, Zaragoza, Spain.
Antonio-David Lazaro-SanchezRIO Working Group, Zaragoza, Spain.
Asia Ferrández-AriasDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.
Paula Rodríguez PayáDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.
Beatriz Grau MireteDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.
Teresa Quintanar VerduguezDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.
Elena Asensio MartinezDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.
Patricia IranzoRIO Working Group, Zaragoza, Spain.
Ana CallejoRIO Working Group, Zaragoza, Spain.
Mara Cruellas LapeñaRIO Working Group, Zaragoza, Spain.
Jacobo Gómez UllaRIO Working Group, Zaragoza, Spain.
Alvaro Rodriguez-LescureDepartment of Medical Oncology, FISABIO, Hospital General Universitario de Elche, Alicante, Spain.ORCID 0000-0002-6823-5290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant advances in oncology, cancer care globally continues to face critical challenges, including stark disparities in access, insufficient preventive focus, fragmented primary health care (PHC) integration, unsustainable financing models, workforce shortages, and inadequate community involvement. This paper revisits the Alma Ata Declaration's principles-health equity, universal access, preventive care, and community participation-as a conceptual framework to address these persistent issues in cancer care. We highlight opportunities to strategically integrate oncology services within strengthened PHC systems, balancing centralized specialist resources with decentralized community-based care. Evidence from diverse settings illustrates how reinforcing PHC infrastructures enhances preventive measures, early detection, and survivorship care, thus mitigating geographic and socioeconomic disparities. Sustainable financing mechanisms and targeted workforce strategies, including task-shifting and multidisciplinary training, are proposed as essential components. Effective community engagement models demonstrate improved care relevance, acceptance, and outcomes. Additionally, we emphasize the critical role of health policy alignment with universal health coverage objectives, robust pharmacoeconomic evaluations, and evidence-based national cancer control plans. Integrating Alma Ata's principles into contemporary oncology provides a viable, scalable model to advance equitable, accessible, and sustainable cancer care globally, laying the theoretical groundwork for future research initiatives and informed policy development.

Indexed as

Medical OncologyNeoplasmsGlobal HealthHealth EquityHealth PolicyHealth Services AccessibilityHumansPrimary Health CareAlma Atacancerdisparitiesglobal oncologyhealth equityhealth policyhealth systemsprimary health carepublic healthuniversal health coverage

Identifiers

PMID40735860
PMCPMC12317243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.